Apple
AAPL
Oracle
ORCL
Adobe
ADBE
Ecopetrol
EC
D.R. Horton
DHI
US Stock MarketDetailed Quotes
ELTX Elicio Therapeutics
- 5.050
- -0.100-1.94%
Close Dec 18 16:00 ET
54.50MMarket Cap-1.16P/E (TTM)
5.090High5.000Low39.33KVolume5.070Open5.150Pre Close199.42KTurnover0.47%Turnover RatioLossP/E (Static)10.79MShares11.45052wk High-2.87P/B42.48MFloat Cap2.96052wk Low--Dividend TTM8.41MShs Float263.000Historical High--Div YieldTTM1.75%Amplitude2.960Historical Low5.071Avg Price1Lot Size
About Elicio Therapeutics Company
Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.
Company Profile
SymbolELTX
Company NameElicio Therapeutics
Listing DateFeb 5, 2021
Founded2011
CEOMr. Robert Connelly
MarketNASDAQ
Employees32
Fiscal Year Ends12-31
Address451 D Street,5th floor, Suite 501
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02210
Phone1-857-209-0050
Websitehttp://www.elicio.com
Company Executives
- Name
- Position
- Salary
- Robert Connelly
- Chief Executive Officer, President, Director, Principal Accounting Officer and Principal Financial Officer
- 678.30K
- Dr. Peter DeMuth, PhD
- Chief Scientific Officer
- --
- Dr. Christopher Haqq, M.D.,PhD
- Executive Vice President, Head of Research and Development and Chief Medical Officer
- 673.82K
- Dr. Julian Ada PhD
- Chairman of the Board
- 96.05K
- Yekaterina Chudnovsky
- Director
- 48.68K
- Dr. Jay R. Venkatesan, M.D.
- Director
- 45.76K
- Dr. Allen R. Nissenson,M.D.
- Independent Director
- 91.22K
- Karen J. Wilson
- Independent Director
- 101.02K
- Carol Gail Ashe
- Independent Director
- 71.59K
- Dr. Robert R. Ruffolo, Jr, Ph.D
- Independent Director
- 63.26K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.